Evaluation of medication adherence in Lebanese hypertensive patients

Journal of Epidemiology and Global Health

Volumn 6, Issue 3, 2016, Pages 157-167

  Yassine, Mohammad ^a   Al Hajje, Amal ^a   Awada, Sanaa ^a   Rachidi, Samar ^a   Zein, Salam ^a   Bawab, Wafa ^a   Bou Zeid, Mayssam ^a   El Hajj, Maya ^a   Salameh, Pascale ^a  

^a LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Blood pressure; Hypertension; Lebanon; Medication adherence; Morisky scale

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NON PRESCRIPTION DRUG;

ADULT; ARTICLE; BIVARIATE ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; COMORBIDITY; CONSULTATION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY COMPLIANCE; DISEASE DURATION; DRUG COST; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; INDIVIDUAL BEHAVIOR ASSESSMENT; LEBANESE; LEBANON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION COMPLIANCE; MODIFIED MORISKY MEDICATION ADHERENCE SCALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; QUESTIONNAIRE; SMOKING; SOCIAL STATUS; SODIUM RESTRICTION; SPORT; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; UNSPECIFIED SIDE EFFECT; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEBANON; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES;

EID: 84938635052     PISSN: 22106006     EISSN: 22106014     Source Type: Journal    
DOI: 10.1016/j.jegh.2015.07.002     Document Type: Article

References (30)

1. [1] Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003), 1206–1252.
2. [2] Kearney, P.M., Whelton, M., Reynolds, K., Whelton, P.K., He, J., Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005), 217–223.
3. [3] Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., Butler, J., Dracup, K., Ezekowitz, M.D., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123 (2011), 933–944.
4. [4] Burt, V.L., Whelton, P., Roccella, E.J., Brown, C., Cutler, J.A., Higgins, M., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25 (1995), 305–313.
5. [5] Berenson, G.S., Srinivasan, S.R., Bao, W., Newman, W.P., Tracy, R.E., Wattigney, W.A., The Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338 (1998), 1650–1656.
6. [6] Thompson, D.W., Furlan, A.J., Clinical epidemiology of stroke. Neurol Clin 14 (1996), 309–315.
7. [7] Lee, G.K., Wang, H.H., Liu, K.Q., Cheung, Y., Morisky, D.E., Wong, M.C., Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One, 8, 2013, e62775.
8. [8] Wolf-Maier, K., Cooper, R.S., Kramer, H., Banegas, J.R., Giampaoli, S., Joffres, M.R., et al. Hypertension treatment and control in five European Countries, Canada, and the United States. Hypertension 43 (2004), 10–17.
9. [9] Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. http://www.who.int/chronic_conditions/en/adherence_report.pdf; 2003 (accessed March 1, 2014).
10. [10] Mant, J., McManus, R.J., Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens 20 (2006), 551–553.
11. [11] Stewart, R.B., Caranasos, G.J., Medication compliance in the elderly. Clin Pharmacol Ther 73 (1989), 1551–1563.
12. [12] Khalil, S.A., Elzubier, A.G., Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens 15 (1997), 561–565.
13. [13] Osterberg, L., Blaschke, T., Drug therapy: adherence to medication. N Engl J Med 353 (2005), 487–497.
14. [14] Payne, K.A., Esmond-White, S., Observational studies of antihypertensive medication use and compliance. is drug choice a factor in treatment adherence?. Curr Hypertens Rep 2 (2000), 515–524.
15. [15] Wang, P.S., Bohn, R.L., Knight, E., Glynn, R.J., Mogun, H., Avorn, J., Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17 (2002), 504–511.
16. [16] Almas, A., Hameed, A., Ahmed, B., Islam, M., Compliance to antihypertensive therapy. J Coll Physicians Surg Pak 16 (2006), 23–26.
17. [17] Charan, J., Biswas, T., How to calculate sample size for different study designs in medical research?. Indian J Psychol Med 35 (2013), 121–126.
18. [18] Morisky, D.E., Ang, A., Krousel-Wood, M., Ward, H.J., Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10 (2008), 348–354.
19. [19] van der Sande, M.A., Milligan, P.J., Nyan, O.A., Rowley, J.T., Banya, W.A., Ceesay, S.M., et al. Blood pressure patterns and cardiovascular risk factors in rural and urban Gambian communities. J Hum Hypertens 14 (2000), 489–496.
20. [20] Hyre, A.D., Krousel-Wood, M.A., Muntner, P., Kawasaki, L., DeSalvo, K.B., Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 9 (2007), 179–186.
21. [21] Oliveira-Filho, A.D., Barreto-Filho, J.A., Neves, S.J., Neves, D.P., Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol 99 (2012), 649–658.
22. [22] Marentette, M.A., Gerth, W.C., Billings, D.K., Zarnke, K.B., Antihypertensive persistence and drug class. Can J Cardiol 18 (2002), 649–656.
23. [23] Saounatsou, M., Patsi, O., Fasoi, G., Stylianou, M., Kavga, A., Economou, O., et al. The influence of the hypertensive patient's education in compliance with their medication. Public Health Nurs 18 (2001), 436–442.
24. [24] Korb-Savoldelli, V., Gillaizeau, F., Pouchot, J., Lenain, E., Postel-Vinay, N., Plouin, P.F., et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich) 14 (2012), 429–434.
25. [25] Iskedjian, M., Einarson, T.R., MacKeigan, L.D., Shear, N., Addis, A., Mittmann, N., et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy evidence from a meta-analysis. Clin Ther 24 (2002), 302–316.
26. [26] George, J., Phun, Y.T., Bailey, M.J., Kong, D.C., Stewart, K., Development and validation of the medication regimen complexity index. Ann Pharmacother 38 (2004), 1369–1376.
27. [27] Krousel-Wood, M., Joyce, C., Holt, E., Muntner, P., Webber, L.S., Morisky, D.E., et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension 58 (2011), 804–810.
28. [28] Ried, L.D., Tueth, M.J., Handberg, E., Kupfer, S., Pepine, C.J., A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST). Psychosom Med 67 (2005), 398–406.
29. [29] Webb, A.J., Fischer, U., Mehta, Z., Rothwell, P.M., Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and metaanalysis. Lancet 375 (2010), 906–915.
30. [30] Pickering, T.G., James, J.D., Boddie, C., Harshfield, G.A., Blank, S., Laragh, J.H., How common is white coat hypertension?. JAMA 259 (1988), 225–228.